Template:Epidural compression syndromes management: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
===General [[Epidural compression syndromes|Epidural Compression Syndrome]] Management=== | |||
*[[Dexamethasone]]: at least 16 mg IV as soon as possible after assessment<ref>Metastatic spinal cord compression: Diagnosis and management of | *[[Dexamethasone]]: at least 16 mg IV as soon as possible after assessment<ref>Metastatic spinal cord compression: Diagnosis and management of | ||
patients at risk of or with metastatic spinal cord compression. Full Guideline. November 2008. Developed for NICE by the National Collaborating Centre for Cancer. ©2008 National Collaborating Centre for Cancer</ref> | patients at risk of or with metastatic spinal cord compression. Full Guideline. November 2008. Developed for NICE by the National Collaborating Centre for Cancer. ©2008 National Collaborating Centre for Cancer</ref> | ||
*Consult spine service | *Consult spine service | ||
*Consider foley for bladder decompression | *Consider foley for bladder decompression | ||
Revision as of 18:17, 19 August 2018
General Epidural Compression Syndrome Management
- Dexamethasone: at least 16 mg IV as soon as possible after assessment[1]
- Consult spine service
- Consider foley for bladder decompression
- ↑ Metastatic spinal cord compression: Diagnosis and management of patients at risk of or with metastatic spinal cord compression. Full Guideline. November 2008. Developed for NICE by the National Collaborating Centre for Cancer. ©2008 National Collaborating Centre for Cancer